Show simple item record

dc.contributor.authorTeoh, Stephanie W. K.
dc.contributor.authorHattingh, Laetitia
dc.contributor.authorLebedevs, Tamara
dc.contributor.authorParsons, Richard
dc.date.accessioned2017-11-17T04:51:05Z
dc.date.available2017-11-17T04:51:05Z
dc.date.issued2017
dc.identifier.issn1445-937X
dc.identifier.doi10.1002/jppr.1241
dc.identifier.urihttp://hdl.handle.net/10072/352703
dc.description.abstractAim: The objectives of this study were to evaluate clinical interventions recorded by pharmacists in an Australian principal referral and specialist women's and newborns' hospital, as well as to identify common medications involved in each specialty area (neonatology, obstetrics and gynaecology), to assess the risks of medication-related problems (MRPs) likely to have been prevented, and to obtain institution-specific MRPs for future staff education. Methods: This retrospective, observational study involved an analysis of all interventions documented by pharmacists from January 2005 to December 2014. The interventions recorded were collated according to ward, medication involved, description of the intervention and the risk classification. Results: There were a total of 14 085 interventions documented over 10 years; 60.33% made in obstetric patients, 28.71% in gynaecology patients and 10.96% in neonates. The three main intervention types were: (i) dose/frequency/time incorrect (25.70%, n = 3260); (ii) prescribing clarification (21.77%, n = 3066); and (iii) medicine omission (15.21%, n = 2143). An average of 12.02% of the interventions were regarded as high-risk and 0.85% as extreme-risk. Of the MRPs documented within each specialty, the prevalence of extreme risk interventions was higher in the neonatal ward. Discussion: The most common intervention was identifying incorrect medication dose/frequency/time. Common medications involved in the MRPs included: opioids and antihypertensives in gynaecology; parenteral nutrition and gentamicin in neonatology; and opioids and non-steroidal anti-inflammatory drugs (NSAIDs) in obstetrics. The medications involved in high and extreme risk MRPs included gentamicin, opioids and NSAIDs. Conclusion: This study demonstrates that hospital pharmacists contribute to the reduction of MRPs, including some potentially fatal adverse medicine events. These findings also enable targeted, site-specific education, which is valuable in improving patient safety.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherSociety of Hospital Pharmacists of Australia
dc.relation.ispartofpagefrom277
dc.relation.ispartofpageto286
dc.relation.ispartofissue4
dc.relation.ispartofjournalJournal of Pharmacy Practice and Research
dc.relation.ispartofvolume47
dc.subject.fieldofresearchPharmacology and pharmaceutical sciences
dc.subject.fieldofresearchClinical pharmacy and pharmacy practice
dc.subject.fieldofresearchcode3214
dc.subject.fieldofresearchcode321403
dc.titleAnalysis of clinical intervention records by pharmacists in an Australian principal referral and specialist women's and newborns' hospital
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorHattingh, Laetitia L.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record